Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years

European Journal of Endocrinology

Volumn 161, Issue 6, 2009, Pages 911-916

  Shiang, Jeng Chuan ^a   Cheng, Chih Jen ^b   Tsai, Ming Kai ^a   Hung, Yi Jen ^b   Hsu, Yu Juei ^b   Yang, Sung Sen ^b   Chu, Shi Jye ^b   Lin, Shih Hua ^b  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; POTASSIUM CHLORIDE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHINESE; CLINICAL TRIAL; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; FREE THYROXINE INDEX; HEART RATE; HEMIPLEGIA; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOKALEMIC PERIODIC PARALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REBOUND; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THYROID FUNCTION TEST; THYROTOXIC PERIODIC PARALYSIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MIDDLE AGED; PARALYSES, FAMILIAL PERIODIC; POTASSIUM; POTASSIUM CHLORIDE;

EID: 72949087543     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0553     Document Type: Article

References (39)

1. Lin SH. Thyrotoxic periodic paralysis. Mayo Clinic Proceedings 2005 80 99-105.
2. Kung AW. Thyrotoxic periodic paralysis: a diagnostic challenge. Journal of Clinical Endocrinology and Metabolism 2006 91 2490-2495.
3. Ko GT, Chow CC, Yeung VT, Chan HH, Li JK & Cockram CS. Thyrotoxic periodic paralysis in a Chinese population. Quarterly Journal of Medicine 1996 89 463-468.
4. Lin SH, Lin YF, Chen DT, Chu P, Hsu CW & Halperin ML. Laboratory tests to determine the cause of hypokalemia and paralysis. Archives of Internal Medicine 2004 164 1561-1566.
5. Lin SH, Hsu YD, Cheng NL & Kao MC. Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in Chinese patients with hypokalemic periodic paralysis. American Journal of the Medical Sciences 2005 329 66-70.
6. Magsino CH Jr & Ryan AJ Jr. Thyrotoxic periodic paralysis. Southern Medical Journal 2000 93 996-1003.
7. Tran HA, Kay SE, Kende M, Doery JC, Colman PG & Read A. Thyrotoxic, hypokalaemic periodic paralysis in Australasian men. Internal Medicine Journal 2003 33 91-94.
8. Goh SH. Thyrotoxic periodic paralysis: reports of seven patients presenting with weakness in an Asian emergency department. Emergency Medicine Journal 2002 19 78-79.
9. Hsu YJ, Lin YF, Chau T, Liou JT, Kuo SW & Lin SH. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. American Journal of the Medical Sciences 2003 326 128-132.
10. Lin SH, Lin YF & Halperin ML. Hypokalaemia and paralysis. Quarterly Journal of Medicine 2001 94 133-139.
11. Lin YF, Wu CC, Pei D, Chu SJ & Lin SH. Diagnosing thyrotoxic periodic paralysis in the ED. American Journal of Emergency Medicine 2003 21 339-342.
12. Lin SH, Chu P, Cheng CJ, Chu SJ, Hung YJ & Lin YF. Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio. Critical Care Medicine 2006 34 2984-2989.
13. Lien YH. A new diagnostic test for an old diagnostic challenge: thyrotoxic periodic paralysis. Critical Care Medicine 2006 34 3053-3054.
14. Manoukian MA, Foote JA & Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Archives of Internal Medicine 1999 159 1601-1606.
15. Lu KC, Hsu YJ, Chiu JS, Hsu YD & Lin SH. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. American Journal of Emergency Medicine 2004 22 544-547.
16. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine 1992 71 109-120.
17. Shayne P & Hart A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Annals of Emergency Medicine 1994 24 736-740.
18. Yu TS, Tseng CF, Chuang YY, Yeung LK & Lu KC. Potassium chloride supplementation alone may not improve hypokalemia in thyrotoxic hypokalemic periodic paralysis. Journal of Emergency Medicine 2007 32 263-265.
19. Halperin ML & Kamel KS. Potassium. Lancet 1998 352 135-140.
20. Sterns RH, Cox M, Feig PU & Singer I. Internal potassium balance and the control of the plasma potassium concentration. Medicine 1981 60 339-354.
21. Chan A, Shinde R, Chow CC, Cockram CS & Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 1991 303 1096-1099.
22. Ginsberg AM, Clutter WE, Shah SD & Cryer PE. Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. Journal of Clinical Investigation 1981 67 1785-1791.
23. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, Angelini V, Fazio S & Sacca L. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 2001 104 3076-3080.
24. Levey GS & Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. American Journal of Medicine 1990 88 642-646.
25. Guthrie GP Jr, Curtis JJ & Beilman KM. Hypophosphatemia in thyrotoxic periodic paralysis. Archives of Internal Medicine 1978 138 1284-1285.
26. Norris KC, Levine B & Ganesan K. Thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. American Journal of Kidney Diseases 1996 28 270-273.
27. Mosekilde L, Christensen MS, Melsen F & Sorensen NS. Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: chemical quantities in serum and urine. Acta Endocrinologica 1978 87 743-750.
28. Katz AI, Emmanouel DS & Lindheimer MD. Thyroid hormone and the kidney. Nephron 1975 15 223-249.
29. Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, Kazama JJ, Fukagawa M & Noguchi S. Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation. Journal of Clinical Endocrinology and Metabolism 2005 90 4211-4215.
30. Rabelink TJ, Koomans HA, Hene RJ & Dorhout Mees EJ. Early and late adjustment to potassium loading in humans. Kidney International 1990 38 942-947.
31. Huth EJ, Squires RD & Elkinton JR. Experimental potassium depletion in normal human subjects. II. Renal and hormonal factors in the development of extracellular alkalosis during depletion. Journal of Clinical Investigation 1959 38 1149-1165.
32. Hiatt N, Chapman LW & Davidson MB. Influence of epinephrine and propranolol on transmembrane K transfer in anuric dogs with hyperkalemia. Journal of Pharmacology and Experimental Therapeutics 1979 209 282-286.
33. Brown MJ, Brown DC & Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. New England Journal of Medicine 1983 309 1414-1419.
34. Yeung RT & Tse TF. Thyrotoxic periodic paralysis. Effect of propranolol. American Journal of Medicine 1978 57 584-590.
35. Tassone H, Moulin A & Henderson SO. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. Journal of Emergency Medicine 2004 26 157-161.
36. Birkhahn RH, Gaeta TJ & Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. Journal of Emergency Medicine 2000 18 199-202.
37. Lin SH & Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. American Journal of Kidney Diseases 2001 37 620-623.
38. Huang TY & Lin SH. Thyrotoxic hypokalemic periodic paralysis reversed by propranolol without rebound hyperkalemia. Annals of Emergency Medicine 2001 37 415-416.
39. Shafiee MA, Charest AF, Cheema-Dhadli S, Glick DN, Napolova O, Roozbeh J, Semenova E, Sharman A & Halperin ML. Defining conditions that lead to the retention of water: the importance of the arterial sodium concentration. Kidney International 2005 67 613-621.